Choi et al. administered diet-induced obese mice with the treatment of DGAT2's antisense oligonucleotide (ASO) to inhibit DGAT2 expression and found that fatty liver and hyperlipidemia were significantly improved [40]. The gene discussed is DGAT2; the disease is Hepatic steatosis.